IGF‑1 LR3 1 mg Long‑Acting Growth Factor Peptide – Overview

This GMP‑certified peptide is the long‑acting version of insulin‑like growth factor‑1. The LR3 modification extends the half‑life to roughly 20 hours, making the IGF‑1 LR3 1 mg Long‑Acting Growth Factor Peptide the preferred tool for anabolic‑research, muscle‑hypertrophy and cellular‑proliferation studies. Its high purity (≥ 99 %) and endotoxin‑free status ensure reliable results.

Key Benefits

• Extended activity – LR3 reduces IGFBP‑3 binding, giving a ~20‑hour half‑life.
• High purity – ≥ 99 % purity verified by HPLC, endotoxin‑free.
• Versatile applications – suitable for in‑vitro cell culture, animal models and ex‑vivo tissue studies.

Technical Specifications

Specification	Detail
Peptide	IGF‑1 LR3 – 1 mg per vial
Purity	≥ 99 % (HPLC)
Form	Lyophilized powder, amber glass vial (1 mL reconstitution volume)
Storage	–20 °C, desiccated; protect from light & moisture
Shelf‑life	24 months when stored as recommended
SKU	PL‑IGF1‑LR3‑1‑MG
GTIN / UPC	019876543216
Manufacturer	PrymaLab

Reconstitution & Recommended Use

1. Reconstitute the vial with **1 mL sterile bacteriostatic water** → final concentration **1 mg / mL** (1000 µg / mL). This provides a ready‑to‑use solution of the IGF‑1 LR3 1 mg Long‑Acting Growth Factor Peptide**.
2. In‑vitro dose: **10‑100 µg/mL** added to culture medium (adjust per assay).
3. In‑vivo rodent dose: **0.5‑2 mg/kg** sub‑cutaneously, once daily or every other day.
4. Maximum single dose: **5 mg** per animal per day.

Safety Disclaimer

This product is supplied for **personal, non‑clinical research use only**. It is **not a medication** and does **not** diagnose, treat, cure or prevent any disease. Pregnant or nursing individuals, people with known medical conditions, or anyone taking prescription medication should consult a qualified health professional before use. Keep out of reach of children.